Biosimilars: A revolution for biologics in the pharmaceutical industry
This project report is submitted in partial fulfilment of the requirements for the degree of Bachelor of Pharmacy, 2017.
Príomhchruthaitheoir: | Moreino, Shannon Sherwin |
---|---|
Rannpháirtithe: | Kabir, Eva Rahman |
Formáid: | Project report |
Teanga: | English |
Foilsithe / Cruthaithe: |
BRAC University
2018
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/9331 |
Míreanna comhchosúla
-
Biologics and Biosimilars as Treatment Options for Psoriasis
de réir: Moya, Amena Khatun
Foilsithe / Cruthaithe: (2023) -
Biosimilar in lymphoma treatment
de réir: Tanisha, Mehrin Haque
Foilsithe / Cruthaithe: (2021) -
Biosimilar insulins: a potential option in the treatment of Diabetes
de réir: Tabassum, Turana
Foilsithe / Cruthaithe: (2022) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
de réir: Tania, Umme
Foilsithe / Cruthaithe: (2021) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
de réir: Tania, Umme
Foilsithe / Cruthaithe: (2023)